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Peroxisomal matrix proteins are synthesized on cytosolic ribosomes and rapidly 
transported into the organelle by a complex machinery. The data gathered in recent years 
suggest that this machinery operates through a syringe-like mechanism, in which the 
shuttling receptor PEX5 - the “plunger” - pushes a newly synthesized protein all the way 
through a peroxisomal transmembrane protein complex - the “barrel” - into the matrix of 
the organelle. Notably, insertion of cargo-loaded receptor into the “barrel” is an ATP-
independent process, whereas extraction of the receptor back into the cytosol requires its 
monoubiquitination and the action of ATP-dependent mechanoenzymes. Here we review 
the main data behind this model.  
 
Abbreviations 
AAA, ATPases associated with diverse cellular activities; DTM, docking/translocation 
module; DUB, deubiquitinating enzyme; GSH, glutathione; PIM, peroxisomal matrix 
protein import machinery; PTS, peroxisomal targeting sequence; REM, receptor export 
module; RING, really interesting new gene; TPR, tetratricopeptide repeats. 
 
Introduction 
Peroxisomes are single membrane-bound organelles found in almost all eukaryotic 
organisms [1]. In mammals, they have a relatively simple protein composition, harboring 
approximately 100 different proteins [2–4]. Despite their structural and functional 
simplicity, peroxisomes are of vital importance for human health and development, as 
underlined by a group of genetic diseases, the peroxisomal biogenesis disorders, in which 
peroxisomes are partially or even completely defective [5, 6]. These disorders are caused 
by mutations in genes encoding peroxins, proteins specifically involved in peroxisome 
biogenesis [5–8]. There are 16 such proteins in mammals. Three are involved in 
peroxisome proliferation (reviewed in [9, 10]). A set of three others is required for 
peroxisome membrane biogenesis (reviewed in [11, 12]). The remaining 10 peroxins, 
together with a few additional components, comprise the peroxisomal matrix protein 
import machinery (PIM), the topic of this essay. 
Peroxisomal matrix proteins are transported into the organelle within a few minutes after 
synthesis in the cytosol [13]. Their correct sorting depends on peroxisomal targeting 
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sequences (PTSs), small domains in their primary structure that are recognized by 
shuttling receptors [14–17]. There are two kinds of targeting sequences, the so-called 
PTS type 1 and 2 (PTS1 and PTS2, respectively; see Fig. 1a for details). PTS1 proteins 
are transported to the peroxisome by the shuttling receptor PEX5 in all organisms studied 
up to now [17], whereas PTS2 proteins are delivered to the organelle by a protein 
complex comprising PEX5 and PEX7 in mammals, plants and many other organisms [14] 
or PEX7 and a PEX5-like peroxin in yeasts and fungi [14, 18–20] (see Fig. 1a). 
PEX5 comprises two major domains (see Fig. 1b). One, encompassing its C-terminal 
half, consists of two interacting sets of three tetratricopeptide repeats (TPR) which 
provide the binding site for the PTS1 [21–23]. The other, encompassing its N-terminal 
half, is an intrinsically disordered domain [24] and harbors a series of short motifs which 
mediate the interaction of PEX5 with other peroxins [25–27]. In mammals, plants and 
many other organisms, one of these peroxins is PEX7, a 40-kDa WD-repeat protein that 
similarly to PEX5 displays a partially cytosolic, partially peroxisomal localization in vivo 
[16, 28]. PEX7 interacts directly with the PTS2 [29–32] and functions as an ancillary 
factor of PEX5 (or yeasts/fungi PEX5-like peroxins) in the transport of PTS2 proteins to 
the peroxisome [19, 20, 33, 34]. 
 
PEX5 as a holdase-like protein 
One of the most remarkable properties of the PIM is its capacity to accept already 
oligomerized proteins as substrates (reviewed in [35, 36]). Indeed, several studies have 
shown that when two interacting proteins are co-expressed in the same cell, the existence 
of a PTS in one of those proteins is sufficient to ensure a peroxisomal localization for at 
least a fraction of the other protein [37–39]. Those studies led to two conclusions. The 
first, which remains undisputed and is of major importance to understand the mechanism 
of the PIM, was that newly synthesized peroxisomal proteins do not have to be unfolded 
to be translocated across the organelle membrane [37–39]. The second was that most if 
not all peroxisomal proteins are imported into the organelle only after oligomerization in 
the cytosol [35, 36], a generalization that is probably incorrect. Indeed, a growing number 
of observations suggest that many peroxisomal matrix proteins that are oligomeric in 
their native state actually arrive at the organelle matrix as monomers (reviewed in [40]). 
The reason for this does not seem to be simply a kinetic property of the protein transport 
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system, with import of newly synthesized proteins occurring faster than their 
oligomerization in the cytosol. Rather, recent data suggest that there is an active 
mechanism that maintains newly synthesized proteins in a monomeric state in the 
cytosol. Indeed, it was found that PEX5 binds the monomeric versions of several 
peroxisomal enzymes strongly inhibiting their oligomerization [40–42]. This, together 
with the fact that the cytosolic PEX5 concentration is probably large enough to bind all 
newly synthesized proteins that are en route to the organelle matrix, led to the proposal 
that PEX5 is also a chaperone keeping peroxisomal proteins in a near-native monomeric 
conformation thus blocking premature or unspecific interactions [42].  
Interestingly, an analysis of the PEX5-catalase interaction revealed that the N-terminal 
half of PEX5 is required for its holdase-like activity [42]. Actually, this domain alone 
inhibits catalase oligomerization, albeit less potently than the full-length protein. This, 
together with data showing that the N-terminal half of PEX5 from several organisms 
interacts with at least some cargo proteins [43, 44] suggests that this domain of PEX5 
enfolds the cargo protein, thus shielding it from other proteins. It is also possible that a 
segment(s) of the intrinsically disordered N-terminal half of PEX5 acts as an entropic 
bristle [45], excluding other proteins from the vicinity of the cargo protein with which it 
interacts.  
 
Activating the “plunger” – the auto-regulatory mechanism of PEX5 
As described below, PEX5 becomes transiently inserted into a peroxisomal 
transmembrane protein complex – the Docking/Translocation Module (DTM) – at a 
certain stage of the protein transport cycle. Although none of the steps leading to that 
stage require energy from NTP hydrolysis, the subsequent extraction of PEX5 from the 
DTM does consume ATP [46]. Thus, it is not surprising that the PIM avoids futile 
energy-costing cycles by ensuring that only PEX5 molecules carrying a cargo protein 
have access to the DTM [47, 48]. Interestingly, this regulatory mechanism resides not in 
the DTM but rather in PEX5 itself. Indeed, only intact PEX5 molecules are impeded from 
entering the DTM in the absence of cargo proteins; truncated PEX5 species lacking the 
PTS1-binding domain no longer display this property, that is, they enter the DTM in an 
unregulated, constitutive manner [47]. Apparently, the C-terminal half of PEX5 is a cis-
acting repressor of PEX5 DTM-interacting domains, which reside in its N-terminal half. 
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Although structural information on the auto-regulatory mechanism of PEX5 is presently 
unavailable, it is possible that it relies on intramolecular interactions involving these two 
domains of PEX5 (see Fig. 1c). Several findings support this possibility. First, pull-down 
assays using recombinant proteins have shown that the two halves of PEX5 can interact 
with each other [49]. Second, the conformation of the N-terminal half of PEX5 is altered 
when PEX5 binds a PTS1 peptide as assessed by partial proteolysis experiments [50, 51]. 
Finally, a single missense mutation in the PTS1-binding domain of PEX5 that abolishes 
its PTS1-binding capacity induces conformational alterations in the N-terminal half of 
PEX5 and, importantly, also disrupts its auto-regulatory mechanism [50]. 
 
Assembling the syringe – interaction of cargo-loaded receptors with the DTM 
The DTM (the syringe barrel) comprises 5 core components: PEX14, PEX13 and the 
three RING finger proteins PEX2, PEX10 and PEX12 [52, 53]. Despite an abundance of 
information on binary interactions between DTM components [26, 52–62], the precise 
organization of these proteins in the peroxisomal membrane is not known. The fact that 
this protein complex largely falls apart upon solubilization of the peroxisomal membrane 
has complicated its structural characterization [52, 53]. Nevertheless, it is clear that all of 
its components are transmembrane proteins, and that at least two of them, PEX14 and 
PEX13, have the capacity to homoligomerize and to interact directly with PEX5 [25–27, 
51–65]. The PEX5-binding domains of PEX13 are exposed into the cytosol whereas the 
strongest PEX5-binding domain of PEX14 is either deeply embedded in the peroxisomal 
membrane or even exposed into the peroxisome matrix [64, 66–68]. Thus, PEX14 and 
PEX13 are probably the major components of the protein translocation channel (see also 
below). 
The interaction of cargo-loaded PEX5 with the DTM occurs in two steps: docking and 
insertion (see Fig. 2). The first is a reversible step whereas the second is essentially 
irreversible in the absence of ATP [46, 69, 70]. Remarkably, DTM-inserted PEX5 
displays a transmembrane topology, exposing only a small N-terminal domain into the 
cytosol whereas the bulky part of its polypeptide chain faces the organelle matrix [71]. 
Such a topology suggests that cargoes are translocated across the peroxisomal membrane 
by PEX5 itself, when the receptor gets inserted into the DTM [71]. Importantly, insertion 
of PEX5 into the DTM does not require NTP hydrolysis in vitro and, accordingly, the 
6 
same was recently shown to be the case for the peroxisomal import of both PTS1 and 
PTS2 proteins [46, 69, 72]. These findings, together with data showing that protein 
import into peroxisomes is a ionophore-insensitive process [72–74], strongly suggest that 
the driving force for protein translocation across the peroxisome membrane resides in 
simple protein-protein interactions involving PEX5, on one side, and components of the 
DTM, on the other [46, 69, 72].  
The finding that PEX5, an extremely hydrophilic protein lacking any obvious 
phylogenetically conserved membrane-interacting domains, acquires a transmembrane 
topology during the cargo protein translocation step, together with the fact that the 
peroxisomal membrane is impermeable to all but the smallest of the metabolites [75], 
also provides some information on the architecture of the DTM. Indeed, it suggests that 
DTM components form a flexible and gated channel in which cargo-loaded PEX5 
becomes inserted to release its cargo into the peroxisome matrix. We note, however, that 
there are other perspectives. An interesting one can be found in the so-called transient 
pore model [76]. According to that model, protein translocation across the peroxisomal 
membrane is promoted by one or even several PEX5 molecules all of which become 
inserted into the peroxisomal lipid bilayer thus forming the hydrophilic channel through 
which cargoes are translocated [76, 77]. Two arguments seem to be at the root of that 
model. The first derives from the idea that most peroxisomal proteins might be imported 
into peroxisomes after oligomerization in the cytosol. Since some of these oligomers 
expose several PTSs on their surface, they might interact with several PEX5 molecules 
and be presented to the DTM as such [76, 77]. However, as discussed above, peroxisomal 
import of already oligomerized cargoes may not be that frequent. The second argument 
regards the fact that once at the peroxisome, PEX5 cannot be extracted from the organelle 
membrane by treatment with alkaline solutions, a property that might suggest that 
peroxisomal PEX5 is an intrinsic membrane protein (i.e., that it interacts directly with the 
hydrophobic phase of the membrane) [23, 78–80]. However, we have recently found that 
the interaction between PEX5 and PEX14, one of the most abundant components of the 
DTM, is remarkably stable at alkaline pH even in the absence of membrane lipids (Dias 
et al., unpublished). Thus, there is no need to assume that peroxisomal PEX5 interacts 
directly with the hydrophobic phase of the membrane to explain its biochemical 
properties. 
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After insertion of cargo-loaded PEX5 or PEX5
PEX7
 into the DTM, cargoes are released 
into the organelle matrix. Interestingly, and similarly to the insertion step, cargo-release 
is also a NTP-independent event and insensitive to several ionophores [69, 72]. Possibly, 
the receptors undergo conformational alterations during the insertion step which decrease 
their cargo-binding affinity, as is in fact supported by protein-protein interaction studies 
suggesting that some receptor-cargo interactions are decreased or even abolished by 
PEX14 [42, 81, 82]. 
 
The receptor recycling machinery  
After cargo-release the shuttling receptors are extracted from the DTM so that they can 
engage in a new protein transport cycle. This is the only segment of the protein import 
pathway that requires energy input from ATP hydrolysis [46]. Thus, in contrast to many 
other protein import machineries, which use ATP/GTP hydrolysis as the driving force for 
the vectorial translocation of proteins across a membrane [83, 84], the PIM uses ATP not 
for the protein transport process itself, but rather to reset the protein transport system. 
The machinery involved in receptor recycling comprises at least 10 proteins. Three of 
these are the DTM RING peroxins, PEX2, PEX10 and PEX12. They form a subcomplex 
within the DTM, as shown by biochemical and genetic studies in yeasts [53, 85]. Also, 
the RING domains of all three peroxins display ubiquitin-ligase activity in in vitro assays 
[86–89]. 
Three other components of this machinery are PEX1, PEX6, and a poorly conserved tail-
anchored peroxin of the peroxisome membrane called PEX26 in mammals and many 
other organisms, APEM9 in plants and PEX15 in yeasts and some fungi [18, 90–94]. 
These peroxins comprise the so-called Receptor Export Module (REM), a protein 
complex that uses ATP hydrolysis to extract receptors from the DTM [46, 90, 91]. PEX1 
and PEX6 are members of the AAA family of mechanoenzymes; they form a 
heterohexameric ring, best described as a trimer of PEX1/PEX6 heterodimers, which is 
anchored to the peroxisome membrane by PEX26/APEM9/PEX15 [92–98]. Finally, the 
export machinery also comprises ubiquitin, an ubiquitin-activating enzyme, an ubiquitin-
conjugating enzyme (E2D1/2/3, in mammals; the PEX4-PEX22 complex in yeasts, fungi 
and plants), and AWP1, a proposed ubiquitin-binding adaptor of the mammalian 
PEX1/PEX6 complex [99–101]. 
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Disassembling the syringe – recycling of receptors 
Extraction of PEX5 or PEX5
PEX7
 from the DTM involves two distinct steps, namely, 
monoubiquitination of PEX5 and ATP-dependent dislocation of monoubiquitinated 
PEX5 (Ub-PEX5) back into the cytosol. PEX7 is not ubiquitinated during this event but 
its export requires monoubiquitination and dislocation of PEX5 from the DTM. 
Interestingly, Ub-PEX5 and PEX7 seem to leave the DTM separately, with the former 
displaying faster export kinetics than the latter. Apparently, extraction of Ub-PEX5 from 
the DTM also disrupts its interaction with PEX7. How exactly PEX7 is subsequently 
released into the cytosol is still unknown but it might simply involve the spontaneous 
disruption of a weak protein-protein interaction with the DTM [48, 102]. 
Monoubiquitination of PEX5 displays some noteworthy properties. First, in contrast to 
classical ubiquitination which targets lysine residues, the final acceptor of ubiquitin is a 
phylogenetically conserved cysteine residue present in the small cytosol-exposed domain 
of DTM-embedded PEX5 [100, 103] (see Fig. 1b). The reason for this is still not fully 
comprehended but, as discussed elsewhere [104], this type of unconventional 
ubiquitination may, on one hand, allow a redox regulation of the PEX5-mediated protein 
import pathway and, on the other, reduce the probability that dislocated (i.e., cytosolic) 
Ub-PEX5 ends up in the ubiquitin-proteasome pathway. Data supporting both 
possibilities have been provided recently [105, 106]. Second, monoubiquitination of 
PEX5 at the DTM is an integral and mandatory step of the PEX5 peroxisome-cytosol 
cycle, and not the result of some regulatory event occurring at the PIM [103, 104, 107, 
108]. Finally, monoubiquitination of PEX5 is completely dependent on the three RING 
peroxins and occurs only after cargo-dependent insertion of the receptor into the DTM 
[48, 69, 109]. The actual monoubiquitination mechanism remains largely 
uncharacterized. It is known that E2D1/2/3 in mammals and the PEX4-PEX22 complex 
in yeasts are the ubiquitin conjugating enzymes involved in this step [99, 100] but which 
of the RING peroxin(s), if any alone, participate in this reaction remains undefined [110].  
After monoubiquitination, PEX5 is dislocated by the REM. Recognition of Ub-PEX5 by 
the REM probably involves a direct interaction between the ubiquitin moiety and the 
REM because modification of cys11 of DTM-embedded PEX5 with a bulky ubiquitin 
analog results in a PEX5 protein that is no longer an export substrate [103]. Thus, it is not 
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monoubiquitination of PEX5 per se but rather the protein interface provided by an intact 
ubiquitin bound to PEX5 that triggers the REM. However, it is unlikely that the Ub-
PEX5.REM interaction is limited to this single-site contact. Indeed, some recent data 
suggest that PEX5 itself and PEX14 may also interact directly with the REM [90, 111].  
Extraction of DTM-embedded Ub-PEX5 into the cytosol is very fast in vitro (half-life < 2 
min) [48, 70]. This step is absolutely dependent on ATP hydrolysis but the stoichiometry 
of the reaction, i.e., the number of ATPs hydrolyzed per Ub-PEX5 dislocated, is 
unknown. The same is true for the mechanism used by PEX1/PEX6 to extract Ub-PEX5 
from the DTM. Although the structure of the yeast complex was recently determined, the 
data did not unveil its mechanism, as discussed recently [98]. Nevertheless, by analogy 
with other members of the AAA family it was proposed that Ub-PEX5 is moved “into, 
and perhaps even through,” the central pore of the PEX1/PEX6 ring [98]. A recent 
finding might favor the second possibility, i.e., that at least a portion of PEX5 
polypeptide chain is threaded through the REM pore during the extraction step. Indeed, it 
has been shown that a PEX5 protein harboring a bulky EGFP moiety at its C-terminus 
can still enter the DTM, where it is monoubiquitinated and recognized by the REM. 
However, its export is severely compromised resulting in the accumulation of a partially 
dislocated species having most of the PEX5 moiety already exposed into the cytosol 
while the EGFP portion plus a few PEX5 C-terminal residues is still associated with the 
organelle, presumably trapped at the REM [112]. 
 
Closing the cycle – PEX5 deubiquitination 
Dislocation of Ub-PEX5 into the cytosol is followed by its rapid deubiquitination, the last 
step of the PEX5-mediated protein import pathway. The most active deubiquitinating 
enzyme (DUB) involved in this event has been identified in both yeast and mammals. 
These are UBP15 and USP9X, respectively [107, 113]. However, it is clear that these 
enzymes do not provide the only way to deubiquitinate PEX5 because deletion or knock-
down of the corresponding genes does not lead to the accumulation of cytosolic Ub-
PEX5. Possibly, other DUBs also contribute to this reaction. It is also feasible that a 
fraction of Ub-PEX5 is deubiquitinated in a non-enzymatic manner since the labile 
thioester bond linking ubiquitin to PEX5 becomes highly sensitive to nucleophilic attack 
(e.g., by glutathione (GSH)) after extraction of Ub-PEX5 from the DTM [104]. 
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Conclusions and outlook 
Our knowledge on the PEX5-mediated protein import pathway has increased remarkably 
in recent years. Yet, it is evident that there are still large gaps in our understanding of the 
PIM. A particularly large one regards the composition and architecture of the hydrophilic 
channel through which matrix proteins are translocated into the peroxisome matrix. 
Clearly, we need the power of structural biology to get at least some snapshots of how all 
the proteins that comprise the DTM are organized. Another line of research that will 
surely provide valuable information regards the functional/structural characterization of 
the PIM in more divergent/ancient organisms. For instance, some PEX14 proteins (e.g., 
GeneBank acc. number: EJK45126.1, [114]) possess a PUB domain, which is known to 
mediate interactions with p97 [115], a protein that similarly to PEX1/6 is a member of the 
AAA family of mechanoenzymes. If true, this might suggest that at a certain time in 
evolution p97 was the mechanoenzyme in charge of dislocating receptors from the DTM. 
Clearly, we will see many exciting discoveries on the peroxisomal matrix protein import 
machinery in the coming years. 
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Figure 1. A: The peroxisomal targeting signals. The PTS1 is a small peptide present at 
the extreme C-termini of many peroxisomal matrix proteins. It frequently ends with the 
sequence SKL [17]. These proteins are recognized by the shuttling receptor PEX5 [17]. 
The PTS2 is a degenerated nonapeptide found at the N-termini of a few proteins [14]. In 
mammals, plants and many other organisms, PTS2 proteins are transported to the 
peroxisome by a PEX5
PEX7
 protein complex [14], whereas in yeasts and fungi this is done 
by a complex comprising PEX7 and a PEX5-like peroxin [14, 18, 19]. It is possible that 
newly synthesized PTS2 proteins interact first with cytosolic PEX7, and that PEX5 (or 
PEX5-like peroxins) joins the complex subsequently [116, 117]. B: 
Functional/structural domains of PEX5. The N-terminal half of PEX5 is an 
intrinsically disordered region. It contains eight pentapeptide motifs (shown in dark gray) 
all of which have been shown to interact with PEX14 [26, 27]. Some of these motifs also 
interact with PEX13 [26]. The conserved cysteine residue (cysteine 11 in human PEX5), 
and a PEX7/PTS2-binding region (shown in blue; [19, 20, 29, 102, 117] are also 
indicated. The structure of the C-terminal half of human PEX5 is known [21] (PDB ID: 
1FCH). The TPRs (shown in magenta) form the PTS1-binding domain of PEX5. C: The 
auto-regulatory mechanism of PEX5. The hypothetical model shown is based on the 
finding that the C-terminal half of PEX5 is a cis-acting repressor of the DTM-interacting 
domain of PEX5. Free PEX5 oscillates between two conformations, one inactive and the 
other active, the latter being much less populated than the former; cargoes interact with 
the active form of PEX5, maintaining the DTM-interacting region of PEX5 in an active 
state. Transition between inactive and active PEX5 might also be triggered by binding of 
the cargo protein to PEX5; however, this possibility would not explain why over-
expression of PEX5 in cells leads to a partial inhibition of peroxisomal import [118]. 
 
Figure 2. The peroxisomal matrix protein import mechanism. Peroxisomal matrix 
proteins (CP) are synthesized on cytosolic ribosomes and bound by the shuttling receptor 
PEX5 (stage 1a). The PEX5-cargo complex then docks at (stage 1b) and becomes 
inserted into the DTM (stage 2) resulting in cargo translocation across the peroxisomal 
membrane and its release into the organelle matrix. PEX5 is then monoubiquitinated at a 
conserved cysteine residue (cysteine 11 in mammals) (stage 3a), a mandatory 
23 
modification for the subsequent interaction with the receptor export module (REM; stage 
3b). Finally, after the ATP-dependent extraction of monoubiquitinated PEX5 into the 
cytosol (stage 4), PEX5 is deubiquitinated probably by a combination of non-enzymatic 
(e.g., glutathione (GSH)) and enzymatic mechanisms (e.g., USP9X in mammals). Free 
PEX5 (stage 0) can then start a new protein transport cycle. Import of PTS2-containing 
proteins involves the receptor PEX5
PEX7
. PEX7 remains bound to PEX5 during most of 
the steps of this pathway (see also [48, 102]). For simplicity PEX7 is not shown in the 
figure. E1, ubiquitin-activating enzyme, E2, ubiquitin-conjugating enzyme (i.e., 
E2D1/2/3), E3, ubiquitin RING ligases (i.e., PEX2, PEX10 and PEX12), PPi, 
pyrophosphate, Ub, ubiquitin.  
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